Status:
UNKNOWN
HemosprayTM for Gastrointestinal Bleeding From Cancer
Lead Sponsor:
King Chulalongkorn Memorial Hospital
Conditions:
Gastrointestinal Bleeding From Malignancy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Title: The efficacy of hemostatic powder TC-325 versus standard endoscopic treatment for gastrointestinal bleeding from malignancy; a multi-center randomized trial Background: Gastrointestinal (GI) b...
Eligibility Criteria
Inclusion
- Acute upper or lower gastrointestinal bleeding
- Endoscopy shows actively bleeding at index endoscopy (spurting or oozing)
- Bleeding from malignancy
Exclusion
- Less than 18 years old
- Previously included in the trial
- Eastern Cooperative Oncology Group (ECOG) score 3 or 4
- Pregnancy/lactation
- Bleeding from GI sources suspected of not being malignant
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT03855904
Start Date
June 1 2019
End Date
December 31 2022
Last Update
October 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Chulalongkorn Memorial Hospital
Bangkok, Thailand, 10330